Enhanced macrophage antitumor effects of protein A in combination with IFN-γ

Archives of Pharmacal Research

Volumn 22, Issue 3, 1999, Pages 267-273

  Pyo, Suhkneung ^a   Rhee, Dong Kwon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Antitumor activity; Interferon ; Macrophage; NO; Protein A; TNF

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; NITRIC OXIDE; NITRITE; STAPHYLOCOCCUS PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; SERODIAGNOSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MICE; NEUTRALIZATION TESTS; NITRIC OXIDE; NITRITES; STAPHYLOCOCCAL PROTEIN A; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033142565     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976361     Document Type: Article

References (35)

1. Brenton, G., Zeni, L., Cassatella, M. A. and Rossi, F., Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem. Biophys. Res. Commun., 138, 1276-1282 (1986).
2. Carlsen, E. and Prydz, H., Activation of monocytes more than one process. Scand. J., Immunol., 27, 401-404 (1988).
3. Catalona, W. J., Ratliff, T. L and Mccool, R. E., Interferon induced by S. aureus protein A augments natural killing and ADCC. Nature, 291, 77-79 (1981).
4. Decker, T., Lohmann-Mathes, M. L. and Gifford, G., Cell associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol., 138, 957-962 (1987).
5. Ding, A. H., Nathan, C. F. and Stuehr, D. J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol., 141, 2407-2412 (1988).
6. Drysdale, B. E., Agarwal, S and Shin, H. S., Macrophage-mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog. Allergy, 40, 111-161 (1988).
7. Dullens H. F. J., De Weger., R. A., Van Der Maas, M., Den Besten, R J., Vandebriel, R. J. and Den Otter, W., Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection. Cancer Immunol. Immunother., 30, 28-33 (1989).
8. Flick, D. A. and Gifford, G. E., Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J. Immunol., 68, 167-175 (1984).
9. Gautam, S. and Deodhar, S., Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. J. Biol. Response Modif., 8, 560-569 (1989).
10. Good, R. A., Ocasawara., M., Liu, W. T., Lorenz, E. and Day, N. K., Immunosuppressive actions of retroviruses. Lymphology, 23, 56-59 (1990).
11. Hart, P. G., Whity, G. A., Picoli, D. S. and Hamilton, T. A., Synergistic activation of human monocyte by granulocyte macrophage colony stimulating factor (GM-CSF) and interferon gamma (IFN-γ): increased tumor necrosis factor but not interleukin-1 activity. J. Immunol., 141, 1516-1521 (1992).
12. Herriott, M. J. and Leu, R. W., Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity is mediated by interferon-priming and triggering by various agents. J. Interferon Res,. 7, 165-172 (1987).
13. Hibbs, J. B., Tanitor, R. R. and Vavrin, Z., Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science, 235, 473-476 (1987).
14. Hori, K., Ehrke, M. J. and Mihich, E., Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and interferon gamma. Cancer Res., 47, 5068-5073 (1987).
15. Iigo, M., Nakajima, Y., Nishikata, K. and Hoshi, A., Tumor target derived soluble factors synergize with IFN-γ and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J. Biol. Response Modif,. 8, 147-154 (1989).
16. Iigo, M., Sakurai, M., Tamura, T., Saijo, N. and Hoshi, A., Synergistic inhibition of the growth of adenocarcinoma 755 by the combination of interleukin-2 and interferon-beta. Proc. JPN. Acad. Ser B,. 62, 275-278 (1986).
17. Jiang, H., Stewart, C. A., Fast, D. J. and Leu, R. W., Tumor target derived soluble fators synergize with IFN-γ and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J. Immunol., 149, 2137-2146 (1992).
18. Mishra, A., Dwivedi., R D., Verma, A. S. and Ray, R K., Mechanism of enhanced phagocytic response in protein A treated rat macrophages. Immunol. Lett., 34, 289-295 (1992).
19. Morrison, C. J., Brummer, E. and Stevens, D. A., Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages:synergism between tumor necrosis factor and interferon gamma. Infect. Immunol., 57, 2953-2958 (1989).
20. Oda, S., Sato, M., Toyoshima, S. and Osawa, T., Binding of activated macrophages to tumor cells through a macrophage lectin and its role in macrophage tumouricidal activity. J. Biochem., 105, 1040-1043 (1989).
21. Paulnock, D. M. and Lambert, L. E., Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. J. Immunol., 144, 765-773 (1990).
22. Prasad, A. K., Singh, K. P., Saxena, A. K., Mathur, N. K. and Ray, R K., Increased macrophage activity in protein A treated tumor regressed animals. Immunopharmac. Immunotoxicol., 9, 541-561 (1987).
23. Pyo, S., Gangemi, J. D., Ghaffar, A. and Mayer, E. P., Polyl:C-induced antiviral and cytotoxic activities are mediated by different mechanisms. Int. J. Immunopharmac., 15, 477-486 (1993).
24. Pyo, S., The mechanism of poly I:C-induced antiviral activity in peritoneal macrophage. Arch. Pharm. Res., 17, 93-99 (1994).
25. Ray, R K. and Bandyopadhyay, S., Inhibition of rat mammary tumor growth by purified protein A-a potential anti-tumor agent. Immunol. Commun., 12, 453-464 (1983).
26. Ray, P. K., Bandyopadhyay. S., Dohadwala, M., Canchanapan, R and Mobin, J., Antitumor activity with nontoxic doses of protein A. Cancer Immunol. Immunother., 18, 29-34 (1984a).
27. Ray, P. K., Mohammed, J., Allen, P., Raychaudhurl, P., Dohadwala, M., Bandyopadhyay, S. and Mark, R., Effect of frequency of plasma adsorption over purified protein A containing Stapnylococcus aureus on regression of rat mammary adenocarcinomas: Modification of antitumor immune response and tumor histopathology. J. Biol. Resp. Modif., 3, 39-59 (1984b).
28. Sakane, T. and Green, I., Protein A from Staphyloccoccus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes. J. Immunol., 120, 302-311 (1978).
29. Singh, K. P., Saxena, A. K., Prasad, A. K., Dwivedi, P. D., Zaidi, S. I. A. and Ray, P. K., Effect of protein A on mast cell numbers and macrophage phagocytic activity. Immunopharmac. Immunotoxicol., 9, 281-297 (1987).
30. Shukla, Y., Verma, A. S., Mehrotra, N. K. and Ray, R K., Antitumour activity of protein A in a mouse skin model of two-stage carcinogenesis. Cancer Lett., 103, 41-47 (1996).
31. Steele, G., Ankerest, J. and Sjogren, J. O., Alteration in in vitro antitumor activity of tumor-bearer sera by absorption with Staphylococcus aureus Cowan I. Int. J. Cancer, 14, 83-92 (1974).
32. Trinchieri, G., Kobayashi, M., Rosen, M., Loudon, R., Murphy, M. and Perussia, B., Tumor necrosis factor and lymphotoxin induced differentiation of human myeloid cell lines in synergy with immune interferon. J. Exp. Med. 164, 1206-1211 (1986).
33. Uhing, R. J. and Adams, D. O., Molecular events in the activation of murine macrophages. Agents and Actions, 26, 9-14 (1989).
34. Verstovsek, S., Maccubbin, D. L., Ehrke, M. J. and Mihich, E., Tumoricidal activation of murine resident peritoneal macrophages by interleukin-2 and tumor necrosis factor. Cancer Res., 52, 3880-3885 (1992).
35. Verstovsek, S., Maccubbin, D. L., Ehrke, M. J. and Mihich., E., Polymyxin B-mediated lysis of tumor cells. Int. Arch. Allergy Immunol., 100, 47-53 (1993).